The FDA's New Guillain-Barre Warning For the J&J Vaccine Reflects a Small Increased Risk of the Illness
The FDA's New Guillain-Barre Warning For the J&J Vaccine Reflects a Small Increased Risk of the Illness
In a statement, the CDC said the agency has received about 100 reports of Guillain-Barre syndrome among 12.8 million J&J doses that have been administered, a tiny percentage. In most cases, symptoms appeared about two weeks after people received the vaccine, and most of the affected are male, with many over age 50 years., about 3,000 to 6,000 people develop Guillain-Barre each year, generally due to respiratory or intestinal tract infections.
Johnson & Johnson officials said in a statement that “the chance of having [Guillain-Barre] occur is very low, and the rate of reported cases exceeds the background rate by a small degree.”
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA Plans to Warn J&J Vaccine Can Increase Guillain-Barre RiskPeople receiving the Johnson and Johnson COVID-19 vaccine could be at increased risk for developing Guillain-Barre syndrome, a rare neurologic disorder, the FDA is expected to announce according to multiple media reports. Learn more:
Read more »
Guillain-Barre syndrome explained, FDA warns of increased risk of GBS after Johnson & Johnson COVID vaccineThe severity of GBS, which causes muscle weakness, can range from mild to 'life-threatening' says the U.S. National Institutes of Health.
Read more »
FDA expected to add Guillain-Barre syndrome warning to J&J Covid shotThe FDA is preparing to add a warning to Johnson & Johnson's Covid-19 vaccine after receiving preliminary reports of patients developing the rare neurological condition Guillain-Barré syndrome
Read more »
FDA issues new warning on rare autoimmune disorder linked to J&J vaccineFDA warns of increased risk of Guillain-Barre, a rare neurological disorder, following the Johnson & Johnson vaccine after 100 preliminary cases of the syndrome were reported among the 12.5 million doses administered.
Read more »
FDA Adds Warning Of Rare Autoimmune Disorder To J&J VaccineRegulators said the risk of getting Guillain-Barré syndrome from the Johnson & Johnson COVID-19 vaccine was low.
Read more »